BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 5:17:00 PM | Browse: 1382 | Download: 1220
 |
Received |
|
2013-05-14 09:03 |
 |
Peer-Review Started |
|
2013-05-14 15:39 |
 |
To Make the First Decision |
|
2013-06-09 10:15 |
 |
Return for Revision |
|
2013-06-18 13:32 |
 |
Revised |
|
2013-07-04 18:18 |
 |
Second Decision |
|
2013-07-18 17:51 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-07-19 02:17 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2013-07-23 17:08 |
 |
Typeset the Manuscript |
|
2013-09-18 18:19 |
 |
Publish the Manuscript Online |
|
2013-11-19 16:17 |
Category |
Rheumatology |
Manuscript Type |
Minireviews |
Article Title |
Lymphedema and rheumatological disorders
|
Manuscript Source |
Invited Manuscript |
All Author List |
Sibel Eyigör |
Funding Agency and Grant Number |
|
Corresponding Author |
Sibel Eyigor, MD, Associate Professor, Physical Therapy and Rehabilitation Department, Faculty of Medicine, Ege University, Erzene Mh., 35100 Bornova, Izmir, Turkey. eyigor@hotmail.com |
Key Words |
Lymphedema; Rheumatoid arthritis; Psoriatic arthritis; Ankylosing spondylitis; Systemic sclerosis |
Core Tip |
Coexistence of inflammatory rheumatological diseases and lymphedema is an under-recognized subject. Drawing clinicians’ attention to this issue is important for improving patients’ quality of life. In patients with inflammatory rheumatological disease and lymphedema, although the complex decongestive therapy method is the primary approach, tumor necrosis factor-α inhibitors mentioned in the literature, whose efficacy requires explanation, may also be tried. |
Publish Date |
2013-11-19 16:17 |
Citation |
Eyig?r S. Lymphedema and rheumatological disorders. World J Rheumatol 2013; 3(3): 40-44 |
URL |
http://www.wjgnet.com/2220-3214/full/v3/i3/40.htm |
DOI |
http://dx.doi.org/10.5499/wjr.v3.i3.40 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345